Cart
sales@molnova.com
Labetuzumab
CAS No. 219649-07-7
Labetuzumab( —— )
Catalog No. M37694 CAS No. 219649-07-7
Labetuzumab is a humanized anti-carcinoembryonic antigen (CEA) monoclonal antibody with anticancer activity that inhibits tumor growth and is used in the study of thyroid and colorectal cancer (CRC).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 527 | Get Quote |
|
| 5MG | 660 | Get Quote |
|
| 10MG | 1036 | Get Quote |
|
| 25MG | 1527 | Get Quote |
|
| 50MG | 2052 | Get Quote |
|
| 100MG | 2655 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLabetuzumab
-
NoteResearch use only, not for human use.
-
Brief DescriptionLabetuzumab is a humanized anti-carcinoembryonic antigen (CEA) monoclonal antibody with anticancer activity that inhibits tumor growth and is used in the study of thyroid and colorectal cancer (CRC).
-
DescriptionLabetuzumab is a humanised anti-carcinoembryonic antigen (CEA) monoclonal antibody that inhibits tumour growth and sensitises human medullary thyroid cancer xenografts to Dacarbazine chemotherapy.
-
In Vitro——
-
In VivoLabetuzumab (0.5 mg/rat; i.v.; single) inhibits tumor growth in vivo.Animal Model:Female nu/nu mice (6 to 8-week-old; inject TT cells).Dosage:0.5 mg/rat Administration:Intravenous injection; single (1 day post-tumor cell injection) Result:Significantly delaied growth of tumor, and led to 64%-70% inhibition of tumor size between days 32 and 60.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number219649-07-7
-
Formula Weight145.1 kDa
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Stein R, et al. A humanized monoclonal antibody to carcinoembryonic antigen, labetuzumab, inhibits tumor growth and sensitizes human medullary thyroid cancer xenografts to dacarbazine chemotherapy. Mol Cancer Ther. 2004 Dec;3(12):1559-64. ?
molnova catalog
related products
-
3-(4-prop-2-en-1-ylp...
3-(4-prop-2-en-1-ylpiperazin-1-yl)quinox Antagonism to 2-methyl-5-HT induced contractions in guinea pig ileum
-
Ceapin-A7
Ceapin-A7 is a selective blocker of ATF6α signaling in response to ER stress, with an IC50 of 0.59 μM. Ceapin-A7 can be used to explore both the mechanism of activation of ATF6α and its role in pathological settings.
-
Compound TCFN92660
Hispidin is a natural product, protein kinase C inhibitor, which belongs to the group of 2-pyrones and catechols.
